{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:15:28Z","timestamp":1791227728047,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.pdpdt.2011.08.003","type":"journal-article","created":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T16:44:25Z","timestamp":1317487465000},"page":"16-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Photodiagnosis and photodynamic therapy of peritoneal metastasis of ovarian cancer"],"prefix":"10.1016","volume":"9","author":[{"given":"Laurie","family":"Guyon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ascencio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Collinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Mordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2011.08.003_bib0005","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","article-title":"Estimates of cancer incidence and mortality in Europe in 2008","volume":"46","author":"Ferlay","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.2001.6246","article-title":"Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy","volume":"82","author":"Rose","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0020-7292(96)02721-X","article-title":"Comparison of CA125 assays with abdominopelvic computed tomography and transvaginal ultrasound in monitoring of ovarian cancer","volume":"54","author":"Sugiyama","year":"1996","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0020","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Programm. SEER*Stat Database: populations\u2014total US (1969\u20132007). National Cancer Institute, DCCPS, Surveillance Research Programm, Cancer statistics branch, released April 2011, based on the November 2010 submission (www.seer.cancer.gov)."},{"issue":"Suppl. 10","key":"10.1016\/j.pdpdt.2011.08.003_bib0025","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1002\/cncr.11347","article-title":"Stage at diagnosis of ovarian cancer in the United States, 1992\u20131997","volume":"97","author":"Goodman","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ygyno.2006.07.004","article-title":"Optimal cytoreduction for advanced epithelial ovarian cancer: a commentary","volume":"103","author":"Eisenkop","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0035","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ygyno.2006.03.051","article-title":"What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma?","volume":"103","author":"Chi","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.pdpdt.2011.08.003_bib0040","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0045","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for states IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0050","article-title":"The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal and peritoneal carcinomas","author":"Chi","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.0004-8666.2002.00535.x","article-title":"The place of bowel resection in initial debulking surgery for advanced ovarian cancer","volume":"42","author":"Miller","year":"2002","journal-title":"Aust NZ J Obstet Gynaecol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0060","first-page":"380","article-title":"Photodynamic therapy for cancer","volume":"3","author":"Dolmans","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0065","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s12094-008-0172-2","article-title":"Photodynamic therapy of cancer. Basic principles and applications","volume":"10","author":"Juarranz","year":"2008","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1078\/0171-2985-00221","article-title":"The immunological consequences of photodynamic treatment of cancer: a literature review","volume":"207","author":"Van Duijnhoven","year":"2003","journal-title":"Immunobiology"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0075","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/gyno.2002.6793","article-title":"Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat model","volume":"87","author":"Chan","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0080","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s004640090056","article-title":"5-Aminolevulinic acid-induced fluorescence for the laparoscopic diagnosis of peritoneal metastasis","volume":"15","author":"Canis","year":"2001","journal-title":"Surg Endosc"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0085","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.bjc.6600958","article-title":"Photodynamic diagnosis of ovarian cancer using hexaminolevulinate: a preclinical study","volume":"88","author":"L\u00fcdicke","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0090","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1006\/gyno.1996.4502","article-title":"In vivo fluorescence detection of ovarian cancer in the NuTu19 epithelial ovarian cancer animal model using 5-aminolevlinic acid","volume":"66","author":"Major","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0095","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1562\/2006-04-13-RA-869","article-title":"Laparoscopic photodynamic diagnosis of ovarian cancer peritoneal micrometastatis: an experimental study","volume":"83","author":"Collinet","year":"2007","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/pho.2007.2057","article-title":"Comparison of aminolevulinic acid- and hexylester animolevulinate-induced protoporphyrin IX fluorescence for the detection of ovarian cancer in a rat model","volume":"25","author":"Regis","year":"2007","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0105","unstructured":"Jouve E, Collinet P, Delemer M, Mordon SM. Alternative administrations of hexaminolevulinate for laparoscopic fluorescence diagnosis of metastatic ovarian cancer in a rat model. In: Dequesne J, Wattiez A, De Wilde RL, editors. 15th annual congress of the European society for Gynaecological Endoscopy. Strasbourg, Bologna: Medimond International Proceedings; 5\u20137 October 2006. p. 43\u20136."},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0110","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1038\/sj.bjc.6605436","article-title":"In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring","volume":"101","author":"Zhong","year":"2009","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.pdpdt.2011.08.003_bib0115","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000658-200202000-00014","article-title":"Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis","volume":"235","author":"Gahlen","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0120","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s004640000243","article-title":"Systemic vs local administration of \u03b4-aminolevulinic acid for laparoscopic fluorescence diagnosis of malignant intra-abdominal tumors","volume":"15","author":"Gahlen","year":"2001","journal-title":"Surg Endosc"},{"issue":"3","key":"10.1016\/j.pdpdt.2011.08.003_bib0125","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0039-6060(99)70086-3","article-title":"Improving diagnostic staging laparoscopy using intraperitoneal lavage of \u03b4-aminolevulinic acid for laparoscopic fluorescence diagnosis","volume":"126","author":"Gahlen","year":"1999","journal-title":"Surgery"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0130","first-page":"3904","article-title":"Vascularity and uptake of photosensitizer in small human tumor nodules: implications for intraperitoneal photodynamic therapy","volume":"7","author":"Menon","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0135","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1158\/1078-0432.CCR-04-0359","article-title":"Hypoxia and photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients","volume":"10","author":"Busch","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.pdpdt.2011.08.003_bib0140","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/cncr.20155","article-title":"Laparoscopic fluorescence detection of ovarian carcinoma metastasis using 5-aminolevlinic acid-induced protoporphyrin IX","volume":"100","author":"L\u00f6ning","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0145","first-page":"2983","article-title":"Treatment of murine intraperitoneal ovarian ascetic tumor with hematoporphyrin derivative and laser light","volume":"45","author":"Tochner","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archsurg.1991.01410270062011","article-title":"Technique of photodynamic therapy for disseminated inrtaperitoneal neoplasms: phase I study","volume":"126","author":"Sindelar","year":"1991","journal-title":"Arch Surg"},{"issue":"8","key":"10.1016\/j.pdpdt.2011.08.003_bib0155","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1078-0432.CCR-05-1625","article-title":"A phase II trial of intraperitoneal photodynamic therapy for patients with peritoneal carcinomatosis and sarcomatosis","volume":"12","author":"Hahn","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0160","first-page":"711","article-title":"Patterns of recurrence in patients treated with photodynamic therapy for intraperitoneal carcinomatosis and sarcomatosis","volume":"24","author":"Wilson","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0165","first-page":"1075","article-title":"Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model","volume":"56","author":"Molpus","year":"1996","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.pdpdt.2011.08.003_bib0170","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/jnci\/dji314","article-title":"Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo","volume":"97","author":"Del Carmen","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"10.1016\/j.pdpdt.2011.08.003_bib0175","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1349-7006.2007.00628.x","article-title":"Inrtaperitoneal photodynamic therapy for an ovarian cancer ascite model in Fischer 344 rat using hematoporphyrin monomethyl ether","volume":"98","author":"Song","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1011-1344(01)00249-4","article-title":"Intraperitoneal photodynamic therapy in the Fischer 344 rat using 5-aminolevulinic acid and violet laser light: a toxicity study","volume":"66","author":"Major","year":"2002","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0185","first-page":"3980","article-title":"Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl)methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice","volume":"56","author":"Peterson","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.pdpdt.2010.07.007","article-title":"Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model","volume":"7","author":"Estevez","year":"2010","journal-title":"Photodiagn Photodyn Ther"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0195","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00432-010-0761-7","article-title":"Efficacy of a methyl ester of 5-aminolevulinic acid in photodynamic therapy for ovarian cancers","volume":"136","author":"Wakui","year":"2010","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0200","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbrc.2005.09.021","article-title":"Phototoxicity of hemoporfin to ovarian cancer","volume":"337","author":"Song","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0205","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjc.6690740","article-title":"Minimally-invasive debuling of ovarian cancer in the rat pelvis by means of photodynamic therapy using pegylated photosensitizer PEG-m-THPC","volume":"81","author":"Hornung","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pdpdt.2007.07.003","article-title":"Evaluation of ALA6PDT of ovarian cancer in the Fischer 344 rat tumor model","volume":"4","author":"Ascencio","year":"2007","journal-title":"Photodiagn Photodyn Ther"},{"issue":"2","key":"10.1016\/j.pdpdt.2011.08.003_bib0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1523-1747.2000.00872.x","article-title":"Wavelength and fluence effect on vascular damage with photodynamic therapy on skin","volume":"114","author":"Tsoukas","year":"2000","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.pdpdt.2011.08.003_bib0220","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1751-1097.1998.tb05228.x","article-title":"The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy","volume":"67","author":"Sitnik","year":"1998","journal-title":"Photochem Photobiol"},{"issue":"3","key":"10.1016\/j.pdpdt.2011.08.003_bib0225","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1751-1097.1991.tb03637.x","article-title":"Intravenous vs intraperitoneal sensitizer: complications for intraperitoneal photodynamic therapy","volume":"53","author":"Perry","year":"1991","journal-title":"Photochem Photobiol"},{"issue":"3","key":"10.1016\/j.pdpdt.2011.08.003_bib0230","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0360-3016(93)90066-5","article-title":"Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors","volume":"25","author":"DeLaney","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.pdpdt.2011.08.003_bib0235","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1751-1097.1997.tb03163.x","article-title":"Intraperitoneal photodynamic therapy: comparison of red and green light distribution and toxicity","volume":"66","author":"Veenhuizen","year":"1997","journal-title":"Photochem Photobiol"},{"issue":"5","key":"10.1016\/j.pdpdt.2011.08.003_bib0240","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1245\/ASO.2003.11.005","article-title":"Intraperitoneal photodynamic therapy causes a capillary-leak syndrome","volume":"10","author":"Canter","year":"2003","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0245","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2003.10.001","article-title":"Antiangiogenic photodynamic therapy using Visudyne causes effective suppression of tumor growth","volume":"205","author":"Ichikawa","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0250","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3835(01)00475-X","article-title":"Photodynamic therapy targeted to tumor-induced angiogenic vessels","volume":"167","author":"Kurohane","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0255","first-page":"695","article-title":"Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy","volume":"123","author":"Chen","year":"2008","journal-title":"In J Cancer"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0260","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/(SICI)1096-9101(1999)24:3<178::AID-LSM2>3.0.CO;2-W","article-title":"In vitro and in vivo photosensitizing capabilities of 5-ALA versus Photofrin\u00ae in vascular endothelial cells","volume":"24","author":"Chang","year":"1999","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0265","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1158\/1078-0432.CCR-06-0953","article-title":"Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy","volume":"12","author":"Hahn","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0270","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/bjc.1992.144","article-title":"Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL3 and 139H2 as Ig and F(ab\u2032)2 fragments in experimental ovarian cancer","volume":"65","author":"Molthoff","year":"1992","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.pdpdt.2011.08.003_bib0275","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1021\/mp800006e","article-title":"Combination chemotherapy and photodynamic therapy with Fab\u2032 fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells","volume":"5","author":"Hongrapipat","year":"2008","journal-title":"Mol Pharmaceutics"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0280","first-page":"4762","article-title":"Photoimmunotherapy of human ovarian carcinoma cells ex vivo","volume":"51","author":"Goff","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0285","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/bjc.1996.516","article-title":"Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model","volume":"74","author":"Goff","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0290","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/bjc.1994.330","article-title":"Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model","volume":"70","author":"Goff","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0295","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1006\/gyno.1999.5705","article-title":"Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates","volume":"76","author":"Molpus","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0300","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01323942","article-title":"Measurements on the depth of penetration of light (0.35\u20131.0\u03bcm) in tissue","volume":"14","author":"Eichler","year":"1977","journal-title":"Rad Environ Biophys"},{"issue":"4","key":"10.1016\/j.pdpdt.2011.08.003_bib0305","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/104454701316918925","article-title":"Characterization of light penetration in rat tissues","volume":"19","author":"Melo","year":"2001","journal-title":"J Clin Laser Med Surg"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0310","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1111\/j.1751-1097.2006.tb09824.x","article-title":"Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy","volume":"82","author":"Boere","year":"2006","journal-title":"Photochem Photobiol"},{"issue":"3","key":"10.1016\/j.pdpdt.2011.08.003_bib0315","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1562\/0031-8655(2003)078<0271:MISDAP>2.0.CO;2","article-title":"Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat oesophagus during 5-aminolevulinic acid photodynamic therapy","volume":"78","author":"Boere","year":"2003","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0320","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/lsm.20943","article-title":"The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy and subsequent clinical outcome","volume":"42","author":"Tyrrell","year":"2010","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0325","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/lsm.20629","article-title":"Protoporphyrin X fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy","volume":"40","author":"Ascencio","year":"2008","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0330","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1258\/ebm.2009.009294","article-title":"Fluorescence monitoring of a photosensitizer and prediction of the therapeutic effect of photodynamic therapy for port wine stains","volume":"235","author":"Wang","year":"2010","journal-title":"Exp Biol Med"},{"issue":"22","key":"10.1016\/j.pdpdt.2011.08.003_bib0335","doi-asserted-by":"crossref","first-page":"9319","DOI":"10.1158\/0008-5472.CAN-10-1783","article-title":"Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer","volume":"70","author":"Rizvi","year":"2010","journal-title":"Cancer Res"},{"issue":"18","key":"10.1016\/j.pdpdt.2011.08.003_bib0340","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1093\/jnci\/91.18.1557","article-title":"Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo","volume":"91","author":"Duska","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0345","first-page":"8126","article-title":"Photodynamic therapy: a means to enhanced drug delivery to tumors","volume":"63","author":"Snyder","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0350","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","article-title":"Epidermal growth factor-related peptides and their receptors in human malignancies","volume":"19","author":"Salomon","year":"1995","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0355","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-8722-3-7","article-title":"Ovarian cancer immunotherapy: opportunities, progresses and challenges","volume":"3","author":"Liu","year":"2010","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0360","first-page":"4066","article-title":"Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma","volume":"60","author":"Ferrario","year":"2000","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.pdpdt.2011.08.003_bib0365","first-page":"4473","article-title":"Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF). VEGF receptor 3 and pigment epithelium-derived factor","volume":"44","author":"Schmidt-Erfurth","year":"2003","journal-title":"IOVS"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0370","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s10103-005-0348-8","article-title":"Low-dose photodynamic therapy increases endothelial cell proliferation and VEGF expression in nude mice brain","volume":"20","author":"Zhang","year":"2005","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0375","first-page":"397","article-title":"High expression of GADD-45\u03b1 and VEGF induced tumor recurrence via up-regulation of IL2 after photodynamic therapy using NPe6","volume":"32","author":"Ohtani","year":"2008","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.pdpdt.2011.08.003_bib0380","first-page":"100","article-title":"Experimental study of antiangiogenic and photodynamic therapies combination for treatment of peritoneal carcinomatosis: preliminary results","volume":"32","author":"Piatrouskaya","year":"2010","journal-title":"Exp Oncol"},{"issue":"1","key":"10.1016\/j.pdpdt.2011.08.003_bib0385","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/107327481101800105","article-title":"Antiangiogenic therapies in epithelial ovarian cancer","volume":"18","author":"Teoh","year":"2011","journal-title":"Cancer Control"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0390","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1525-1438.2007.01027.x","article-title":"A multi-institutional evaluation of factors predictive of toxicity and efficacy of bevacizumab for recurrent ovarian cancer","volume":"18","author":"Wright","year":"2008","journal-title":"Int J Gynecol Cancer"},{"issue":"November\u2013December (6A)","key":"10.1016\/j.pdpdt.2011.08.003_bib0395","first-page":"3673","article-title":"Sonodynamic therapy of cancer using novel sonosensitizers","volume":"27","author":"Kuroki","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0400","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ultsonch.2004.03.004","article-title":"Sonodynamic therapy: a review of the synergistic effects of drugs and ultrasound","volume":"11","author":"Rosenthal","year":"2004","journal-title":"Ultrason Sonochem"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0405","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157488509789055036","article-title":"Activated cancer therapy using light and ultrasound\u2014a case series of sonodynamic photodynamic therapy in 115 patients over a 4-year period","volume":"4","author":"Kenyon","year":"2009","journal-title":"Curr Drug Ther"},{"key":"10.1016\/j.pdpdt.2011.08.003_bib0410","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/1011-1344(94)07111-Z","article-title":"Modes of photodynamic vs sonodynamic cytotoxicity","volume":"28","author":"Kessel","year":"1995","journal-title":"J Photochem Photobiol B"}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100011004200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100011004200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:22:20Z","timestamp":1761610940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100011004200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1572100011004200"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2011.08.003","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Photodiagnosis and photodynamic therapy of peritoneal metastasis of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2011.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}